Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Sarvas, M' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 30 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vehmaan-Kreula, P; Puolakkainen, M; Sarvas, M; Welgus, HG; Kovanen, PT
      Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase byhuman monocyte-derived macrophages

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    2. Hyyrylainen, HL; Bolhuis, A; Darmon, E; Muukkonen, L; Koski, P; Vitikainen, M; Sarvas, M; Pragal, Z; Bron, S; van Dijl, JM; Kontinen, VP
      A novel two-component regulatory system in Bacillus subtilis for the survival of severe secretion stress

      MOLECULAR MICROBIOLOGY
    3. Jurgen, B; Hanschke, R; Sarvas, M; Hecker, M; Schweder, T
      Proteome and transcriptome based analysis of Bacillus subtilis cells overproducing an insoluble heterologous protein

      APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
    4. Huhtinen, M; Puolakkainen, M; Laasila, K; Sarvas, M; Karma, A; Leirisalo-Repo, M
      Chlamydial antibodies in patients with previous acute anterior uveitis

      INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
    5. Vitikainen, M; Pummi, T; Airaksinen, U; Wahlstrom, E; Wu, HY; Sarvas, M; Kontinen, VP
      Quantitation of the capacity of the secretion apparatus and requirement for PrsA in growth and secretion of alpha-amylase in Bacillus subtilis

      JOURNAL OF BACTERIOLOGY
    6. Penttila, T; Vuola, JM; Puurula, V; Anttila, M; Sarvas, M; Rautonen, N; Makela, PH; Puolakkainen, M
      Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2)

      VACCINE
    7. Doblhoff-Dier, O; Bachmayer, H; Bennett, A; Brunius, G; Cantley, M; Collins, C; Collard, JM; Crooy, P; Elmqvist, A; Frontali-Botti, C; Gassen, HG; Havenaar, R; Haymerle, H; Lamy, D; Lex, M; Mahler, JL; Martinez, L; Mosgaard, C; Olsen, L; Pazlarova, J; Rudan, F; Sarvas, M; Stepankova, H; Tzotzos, G; Wagner, K
      Safe biotechnology 10: DNA content of biotechnological process waste

      TRENDS IN BIOTECHNOLOGY
    8. Harkonen, T; Puolakkainen, M; Sarvas, M; Airaksinen, U; Hovi, T; Roivainen, M
      Picornavirus proteins share antigenic determinants with heat shock proteins 60/65

      JOURNAL OF MEDICAL VIROLOGY
    9. Hyyrylainen, HL; Vitikainen, M; Thwaite, J; Wu, HY; Sarvas, M; Harwood, CR; Kontinen, VP; Stephenson, K
      D-Alanine substitution of teichoic acids as a modulator of protein foldingand stability at the cytoplasmic membrane/cell wall interface of Bacillus subtilis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    10. Leskela, S; Wahlstrom, E; Kontinen, VP; Sarvas, M
      Lipid modification of prelipoproteins is dispensable for growth but essential for efficient protein secretion in Bacillus subtilis: characterization of the lgt gene

      MOLECULAR MICROBIOLOGY
    11. Leskela, S; Wahlstrom, E; Hyyrylainen, HL; Jacobs, M; Palva, A; Sarvas, M; Kontinen, VP
      Ecs, an ABC transporter of Bacillus subtilis: dual signal transduction functions affecting expression of secreted proteins as well as their secretion

      MOLECULAR MICROBIOLOGY
    12. Haddaoui, E; Chambert, R; Petit-Glatron, MF; Lindy, O; Sarvas, M
      Bacillus subtilis alpha-amylase: the rate limiting step of secretion is growth phase-independent

      FEMS MICROBIOLOGY LETTERS
    13. Doblhoff-Dier, O; Bachmayer, H; Bennett, A; Brunius, G; Burki, K; Cantley, M; Collins, C; Crooy, P; Elmqvist, A; Frontali-Botti, C; Havenaar, R; Haymerle, H; Lelieveld, H; Lex, M; Mahler, JL; Martinez, L; Mosgaard, C; Olsen, L; Pazlarova, J; Rudan, F; Sarvas, M; Stepankova, H; Tzotzos, G; Wagner, K; Werner, R
      Safe biotechnology 9: values in risk assessment for the environmental application of microorganisms

      TRENDS IN BIOTECHNOLOGY
    14. DobloffDier, O; Bachmayer, H; Bennett, A; Brunius, G; Burki, K; Cantley, M; Collins, C; Crooy, P; Elmqvist, A; FrontaliBotti, C; Havenaar, R; Haymerle, H; Lelieveld, H; Lex, M; Mahler, JL; Martinez, L; Mosgaard, C; Olsen, L; Pazlarova, J; Rudan, F; Sarvas, M; Stepankova, H; Tzotzos, G; Wagner, K; Werner, R; Collard, JM
      Safe biotechnology 9: values in risk assessment for the environmental application of microorganisms (vol 17, pg 307, 1999)

      TRENDS IN BIOTECHNOLOGY
    15. Nylenna, M; Andersen, D; Dahlquist, G; Sarvas, M; Aakvaag, A
      Handling of scientific dishonesty in the Nordic countries

      LANCET
    16. Tjalsma, H; Kontinen, VP; Pragai, Z; Wu, HY; Meima, R; Venema, G; Bron, S; Sarvas, M; van Dijl, JM
      The role of lipoprotein processing by signal peptidase II in the Gram-positive eubacterium Bacillus subtilis - Signal peptidase II is required for the efficient secretion of alpha-amylase, a non-lipoprotein

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Pentilla, JM; Anttila, M; Varkila, K; Poulakkainen, M; Sarvas, M; Makela, PH; Rautonen, N
      Depletion of CD8(+) cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice

      IMMUNOLOGY
    18. PENTTILA JM; PYHALA R; SARVAS M; RAUTONEN N
      EXPANSION OF A NOVEL PULMONARY CD3(-)CD4(-POPULATION IN MICE DURING CHLAMYDIA-PNEUMONIAE INFECTION() CD8(+) CELL)

      Infection and immunity
    19. PENTTILA JM; ANTTILA M; PUOLAKKAINEN M; LAURILA A; VARKILA K; SARVAS M; MAKELA PH; RAUTONEN N
      LOCAL IMMUNE-RESPONSES TO CHLAMYDIA-PNEUMONIAE IN THE LUNGS OF BALB CMICE DURING PRIMARY INFECTION AND REINFECTION/

      Infection and immunity (Print)
    20. LELIEVELD HLM; BACHMAYER H; BOON B; BENNETT A; BRUNIUS G; BURKI K; CANTLEY M; COLLARD JM; COLLINS CH; CROOY P; DOBLHOFFDIER O; DUBAKIENE R; ECONOMIDIS I; ELMQVIST A; FRONTALIBOTTI C; HAVENAAR R; HAYMERLE H; KAPPELI O; LEAVER G; LEX M; LUND S; MAHLER JL; MARRIS R; MARTINEZ LJ; MOSGAARD C; NICU M; NORMANDPLESSIER C; OLSEN J; PAZLEROVA J; ROMANTSCHUK M; RUDAN F; SARVAS M; SCHLUMBERGER HD; SZVOBODA G; STEPANKOVA H; TZOTZOS G; VAICUIVENAS V; WAGNER K; WERNER RG; ZHILEVICHA A
      SAFE BIOTECHNOLOGY .8. TRANSPORT OF INFECTIOUS AND BIOLOGICAL-MATERIALS

      Applied microbiology and biotechnology
    21. LESKELA S; KONTINEN VP; SARVAS M
      MOLECULAR ANALYSIS OF AN OPERON IN BACILLUS-SUBTILIS ENCODING A NOVELABC TRANSPORTER WITH A ROLE IN EXOPROTEIN PRODUCTION - SPORULATION AND COMPETENCE

      Microbiology
    22. IDANPAANHEIKKILA I; WAHLSTROM E; MUTTILAINEN S; NURMINEN M; KAYHTY H; SARVAS M; MAKELA PH
      IMMUNIZATION WITH MENINGOCOCCAL CLASS-1 OUTER-MEMBRANE PROTEIN PRODUCED IN BACILLUS-SUBTILIS AND RECONSTITUTED IN THE PRESENCE OF ZWITTERGENT OR TRITON-X-100

      Vaccine
    23. MUTTILAINEN S; IDANPAANHEIKKILA I; WAHLSTROM E; NURMINEN M; MAKELA PH; SARVAS M
      THE NEISSERIA-MENINGITIDIS OUTER-MEMBRANE PROTEIN P1 PRODUCED IN BACILLUS-SUBTILIS AND RECONSTITUTED INTO PHOSPHOLIPID-VESICLES ELICITS ANTIBODIES TO NATIVE P1 EPITOPES

      Microbial pathogenesis
    24. MUTTILAINEN S; BUTCHER SJ; RUNEBERG K; NURMINEN M; IDANPAANHEIKKILA I; WAHLSTROM E; SARVAS M
      HETEROLOGOUS PRODUCTION OF THE P1 PORIN OF NEISSERIA-MENINGITIDIS IN BACILLUS-SUBTILIS - THE EFFECT OF AN N-TERMINAL EXTENSION ON THE PRESENTATION OF NATIVE-LIKE EPITOPES

      Microbial pathogenesis
    25. IDANPAANHEIKKILA I; MUTTILAINEN S; WAHLSTROM E; SAARINEN L; LEINONEN M; SARVAS M; MAKELA PH
      THE ANTIBODY-RESPONSE TO A PROTOTYPE LIPOSOME VACCINE CONTAINING NEISSERIA-MENINGITIDIS OUTER-MEMBRANE PROTEIN P1 PRODUCED IN BACILLUS-SUBTILIS

      Vaccine
    26. JACOBS M; ANDERSEN JB; KONTINEN V; SARVAS M
      BACILLUS-SUBTILIS PRSA IS REQUIRED INVIVO AS AN EXTRACYTOPLASMIC CHAPERONE FOR SECRETION OF ACTIVE ENZYMES SYNTHESIZED EITHER WITH OR WITHOUT PROSEQUENCES

      Molecular microbiology
    27. KONTINEN VP; SARVAS M
      THE PRSA LIPOPROTEIN IS ESSENTIAL FOR PROTEIN SECRETION IN BACILLUS-SUBTILIS AND SETS A LIMIT FOR HIGH-LEVEL SECRETION

      Molecular microbiology
    28. HIMANEN JP; SARVAS M; HELANDER IM
      ASSESSMENT OF NONPROTEIN IMPURITIES IN POTENTIAL VACCINE PROTEINS PRODUCED BY BACILLUS-SUBTILIS

      Vaccine
    29. HIMANEN JP; PYHALA L; OLANDER RM; MERIMSKAYA O; KUZINA T; LYSYUK O; PRONIN A; SANIN A; HELANDER IM; SARVAS M
      BIOLOGICAL-ACTIVITIES OF LIPOTEICHOIC ACID AND PEPTIDOGLYCAN TEICHOIC-ACID OF BACILLUS-SUBTILIS-168 (MARBURG)

      Journal of General Microbiology
    30. SRIKUMAR R; DAHAN D; GRAS MF; SAARINEN L; KAYHTY H; SARVAS M; VOGEL L; COULTON JW
      IMMUNOLOGICAL PROPERTIES OF RECOMBINANT PORIN OF HAEMOPHILUS-INFLUENZAE TYPE-B EXPRESSED IN BACILLUS-SUBTILIS

      Infection and immunity


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/10/20 alle ore 14:40:07